https://techpapersworld.com/wp-content/uploads/2023/08/ILIKOS-Consulting-Group-1280x720.jpg

With the average new drug taking 10 years in clinical development, combined with a $2B+ price tag and 90% failure rate, the clinical research model is no longer sustainable in today’s market conditions. Furthermore, many drug failures happen at the late-stage of development, creating devastating losses and disappointment for patients and their families. The significant growth of AI applications in drug development coupled with the decreasing cost of computing power required to analyze large datasets,...